Plus   Neg

Onyx Pharma Loss Widens In Q1

Onyx Pharmaceuticals, Inc. (ONXX) Wednesday reported a first-quarter loss of $56.2 million or $0.88 per share, which widened from $49.2 million or $0.78 per share in the same period last year.

Adjusted loss for the period was $43.5 million or $0.68 per share, compared to $14.2 million or $0.23 per share last year.

On average, 12 analysts polled by Thomson Reuters expected a loss of $0.63 per share for the first quarter. Analysts' estimates typically exclude special items.

First-quarter revenues increased 7 percent to $72.0 million from $67.1 million last year. Analysts expected revenues of $70.04 million for the period.

Operating expenses for the period totaled $122.8 million, up from $108.5 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Saudi Arabia's oil major Aramco is reportedly planning to list its much hyped initial public offering on the Saudi stock market, Tadawu only. Earlier, the Dhahran-based Saudi Arabian national petroleum company was planning for a wider international listing. Following a disastrous week of public-relations fiascoes involving transportation of pets, United Airlines said Tuesday it is suspending its Petsafe program with immediate effect. PetSafe is United Airlines' specially designed program for transporting animals that are not eligible to travel in the aircraft cabin. The program offers airport-to-airport travel for animals to nearly 300 destinations. Chipotle Mexican Grill, the Mexican food-chain that continues to struggle from its food-borne illness scandal, on Tuesday said it has appointed Chris Brandt as its new Chief Marketing Officer to replace Mark Crumpacker, who resigned last week. Most recently, Brandt worked at Bloomin' Brands, where...
comments powered by Disqus
Follow RTT